FXI | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

520 results for “FXI”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Active, not recruiting

Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects

40 participants · First posted May 6, 2023

A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation

128 participants · First posted Feb 24, 2026

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers

66 participants · First posted Jul 11, 2018

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

9 participants · First posted Jul 10, 2020

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

506 participants · First posted Aug 30, 2021

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

1,200 participants · First posted Sep 16, 2025

A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis

49 participants · First posted Sep 18, 2015

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

1,120 participants · First posted Feb 13, 2026

Active, not recruiting

Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)

4 participants · First posted Feb 20, 2020

Clinical Trial of Factor XIII (FXIII) Concentrate

72 participants · First posted Mar 21, 2008

Page 1 of 36